Chemical activators of C11orf63 engage various cellular signaling pathways to modulate the protein's activity through phosphorylation. Forskolin acts to elevate intracellular cAMP levels by directly stimulating adenylyl cyclase, which shifts the balance of kinase to phosphatase activities favoring the activation of protein kinase A (PKA). PKA, once activated, can phosphorylate C11orf63, thereby enhancing its activity. Similarly, IBMX raises cAMP levels by inhibiting phosphodiesterases, leading to sustained PKA activity and subsequent phosphorylation of C11orf63. PMA, on the other hand, activates protein kinase C (PKC), a kinase that phosphorylates a broad spectrum of proteins. If C11orf63 is among the substrates of PKC, its activation could be influenced by PMA through direct phosphorylation. Epinephrine binds to adrenergic receptors and through G protein-coupled signals also increases cAMP, which again implicates the activation of PKA and potential phosphorylation of C11orf63. Dibutyryl-cAMP, a membrane-permeable cAMP analog, bypasses receptor-mediated pathways to directly activate PKA, leading to the phosphorylation of C11orf63.
Angiotensin II and bradykinin activate G protein-coupled receptors, triggering multiple downstream kinases that could phosphorylate C11orf63. Ionomycin, by increasing intracellular calcium levels, activates calcium-dependent signaling molecules like calmodulin and calmodulin-dependent kinase, which may also target C11orf63 for phosphorylation. Anisomycin activates stress-activated protein kinases, which could include C11orf63 as a phosphorylation target. Insulin triggers the PI3K/Akt pathway leading to the phosphorylation of a wide range of proteins, potentially including C11orf63. EGF, through its receptor tyrosine kinase, initiates signaling cascades that might involve the phosphorylation of C11orf63. Lastly, BAY 11-7082, by inhibiting NF-κB, could alter the phosphorylation state of various proteins, which might affect the phosphorylation and activity state of C11orf63, depending on the protein's relationship with NF-κB signaling. Each of these chemicals, through their unique mechanisms, contributes to the regulation of C11orf63 activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, which prevents the breakdown of cAMP. Elevated cAMP levels can enhance PKA activity, potentially leading to the phosphorylation and activation of C11orf63. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA (CAS 16561-29-8) activates C11orf63 by promoting phosphorylation, aiding in studies on cellular signaling pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which can increase cAMP levels via G protein signaling, leading to activation of PKA. PKA-mediated phosphorylation can activate C11orf63 if it is a PKA substrate. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent proteins like calmodulin and calmodulin-dependent kinase (CaMK). If C11orf63 is regulated by CaMK, ionomycin could lead to its activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases (SAPKs) like JNK. If C11orf63 is a target of SAPKs, its activation could be facilitated by anisomycin through phosphorylation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt pathway, which can phosphorylate and activate various downstream proteins. If C11orf63 is an Akt substrate, insulin could promote its activation. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin binds to B2 receptors and can lead to the activation of PLC, resulting in increased intracellular calcium and activation of PKC. PKC could then phosphorylate and activate C11orf63. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation, which can alter the phosphorylation state of various proteins. If C11orf63 activity is regulated by NF-κB dependent phosphorylation, this inhibitor might paradoxically lead to its activation under certain contexts. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that can permeate cell membranes and activate PKA intracellularly. If C11orf63 is a PKA substrate, dibutyryl-cAMP could facilitate its phosphorylation and activation. | ||||||